Faculty of Medicine,Dentistry and Health Sciences Department of Pathology

Mantamadiotis Laboratory - Cancer Signalling

Contact: Dr Theo Mantamadiotis
Phone: +61 3 8344 5861
Fax: +61 3 8344 4004
Email: theom@unimelb.edu.au

Our research is aimed at unravelling transcriptional and signalling pathways regulating the survival, growth and differentiation of normal cells and cancer cells.


Key Research Areas

Specific interests and expertise includes the investigations into transcriptional and signalling networks involved in neuronal development, neural stem cells and brain cancer stem cells. The laboratory also has an interest and expertise in the design and use of novel animal models of human nervous system pathology.

The CREB signalling pathway in glioma biology:

Much of our effort has focused on understanding how the cAMP Responsive Element Binding (CREB) transcription factor controls neural progenitor cell survival and growth. Studies in transgenic mice and zebrafish have shown that the CREB pathway is important for neural progenitor cell survival and growth. This has led to the hypothesis that the same CREB-dependent mechanisms involved in normal neural progenitor cell survival and growth are also important to the survival and growth of brain tumour progenitor cells. Our laboratory is now investigating the CREB pathway in human brain tumour cells and tumour initiating cells.

Identification of novel genes involved in glioma cell signalling:

Gene expression profiling using massively parallel sequencing/next generation sequencing approaches of tumour cells is aimed at identifying molecular signatures and biomarkers which will help identify novel mechanisms contributing to tumour development and reveal novel drug targets.

Other work:

Collaborations with other research groups allows us to expand our interests to explore common molecular pathways having a role in the pathology of other cell systems/organs, such as the brain (psychosis, addiction, memory, behaviour), peripheral nervous system development, lung development and lung cancer.


Objectives


Major Achievements


Technology


Collaborations

National:

International:


Funding


Recent Publications

top of page